Evidence-based·Last reviewed May 31, 2026·How we grade evidence

Fructo-Oligosaccharides (FOS)

PrebioticFOS

A short-chain fructan prebiotic that reliably increases gut Bifidobacteria at 5–10 g/day. Beyond that bifidogenic effect, clinical benefits are modest and inconsistent. The most common reason people stop FOS is the dose-dependent gas, bloating, and abdominal discomfort — exactly the symptoms IBS patients are often trying to avoid.

Quick decision guide

May help most

Healthy adults who tolerate FODMAPs and want a fiber-based bifidogenic boost; constipation in adults who don't react badly to fermentable fibers.

Common dosing range

5–10 g/day starting low; foods (chicory, garlic, onion) also contribute significant amounts.

When to expect effects

Bifidobacteria shifts within 1–2 weeks; bowel-habit and symptom changes within 2–4 weeks.

Watch out for

Causes gas, bloating, and abdominal discomfort in a dose-dependent way; problematic for many IBS patients given fructans are a high-FODMAP class.

Evidence snapshot

Bifidogenic effect (increased Bifidobacteria)Strong
Constipation / stool frequency in adultsModerate
Calcium absorption (adolescents, postmenopausal)Emerging
IBS symptomsOften worsens
Immune function in healthy adultsLow

What is it

Fructo-oligosaccharides (FOS), also called oligofructose, are short-chain fructans composed of 2-10 fructose units. They are prebiotic fibers found naturally in chicory, Jerusalem artichoke, onions, and other plants, and are widely used as functional food ingredients.

Is it worth it for you?

Use this as a quick fit check, not a diagnosis.

Worth considering if

You're a healthy adult wanting a measurable bifidogenic effect from a low-cost food-based prebiotic
You tolerate beans, onions, garlic, and other high-FODMAP foods without bloating — you'll likely tolerate FOS too
You have mild functional constipation and want to try a soluble prebiotic before laxatives
You're an adolescent or postmenopausal woman wanting modest calcium-absorption support alongside dietary calcium
You're a dietary supplement formulator combining FOS with probiotics in a 'synbiotic' product

Probably skip if

You have IBS (especially IBS-D or mixed) — fructans are a high-FODMAP class and commonly worsen symptoms
You have SIBO or are on a low-FODMAP elimination diet — FOS feeds the wrong microbes for you
You have inflammatory bowel disease in an active flare — fermentation gas can worsen symptoms
You're sensitive to gas, bloating, or rumbling at low doses — start with 2–3 g/day or skip entirely
You're hoping for systemic 'immune support' or weight-loss benefit — the evidence in healthy adults is weak

Evidence at a glance

Bifidogenic effect (gut microbiota modulation)

Strong Evidence
Effect
Dose-dependent increase in fecal Bifidobacteria at ≥5 g/day; saturating effect around 10–20 g/day
Best fit
Healthy adults wanting a measurable microbiota shift toward Bifidobacterium dominance
Time
1–2 weeks for measurable Bifidobacteria changes

Constipation and stool frequency

Good Evidence
Effect
Modest increase in stool frequency and improved consistency at 5–10 g/day; smaller effect than psyllium
Best fit
Adults with mild functional constipation who tolerate fermentable fibers
Time
2–4 weeks at consistent dosing

Calcium absorption (adolescents and postmenopausal women)

Limited Evidence
Effect
~20–25% increase in fractional calcium absorption at 8–15 g/day in adolescents and postmenopausal women
Best fit
Adolescents during peak bone-mineral accrual or postmenopausal women already on adequate dietary calcium
Time
Weeks to detect biomarker changes; bone-outcome trials are longer

Immune function and infection prevention

Limited Evidence
Effect
Modest effects on infection rates and vaccine responses in some trials; not consistent in healthy adults
Best fit
Infants and children (most evidence is in pediatric formula trials); adults with recurrent respiratory infections wanting a low-cost adjunct
Time
Weeks to months in vaccine and infection trials

IBS symptoms

Mixed Evidence
Effect
Often worsens symptoms in IBS; rare improvements not robust
Best fit
None — most IBS patients react adversely to fructans
Time
Often worse within days; not a useful trial

Evidence for 5 uses

AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.

Bifidogenic effect (gut microbiota modulation)

Biomarker support
Strong Evidence

FOS is selectively fermented by Bifidobacterium species in the colon, producing short-chain fatty acids (acetate, propionate, butyrate) and increasing Bifidobacterium counts in stool. The dose-response is well established: ≥5 g/day produces measurable bifidogenic effect, with maximum effect around 1020 g/day. This is the single most reliable physiologic effect of FOS supplementation and the basis for its prebiotic status.

Effect size
Dose-dependent increase in fecal Bifidobacteria at ≥5 g/day; saturating effect around 10–20 g/day
Time to effect
1–2 weeks for measurable Bifidobacteria changes
Best fit
Healthy adults wanting a measurable microbiota shift toward Bifidobacterium dominance
Less likely
Adults with severe FODMAP intolerance or active IBD flares — fermentation may produce more discomfort than benefit

Bottom line: The bifidogenic effect is the only FOS benefit that's consistently demonstrated. Whether the microbiota shift translates to clinical outcomes is less clear.

Constipation and stool frequency

Supplement benefit
Good Evidence

FOS at 510 g/day modestly improves stool frequency and consistency in adults with functional constipation, mediated by increased microbial mass, water-binding, and short-chain fatty acid production. Effect sizes are smaller than psyllium or PEG; tolerability is the main differentiator (FOS produces gas; psyllium doesn't to nearly the same degree).

Effect size
Modest increase in stool frequency and improved consistency at 5–10 g/day; smaller effect than psyllium
Time to effect
2–4 weeks at consistent dosing
Best fit
Adults with mild functional constipation who tolerate fermentable fibers
Less likely
Adults with IBS-related constipation — fructans often worsen overall IBS symptoms even if stool frequency improves

Bottom line: Useful for mild constipation if you tolerate it. Try psyllium first if gas is unwelcome.

Calcium absorption (adolescents and postmenopausal women)

Biomarker support
Limited Evidence

Inulin-type fructans (including FOS) modestly increase fractional calcium absorption by ~2025% at doses of 815 g/day. The effect is most consistently demonstrated in adolescents and postmenopausal womenthe populations with the most active calcium needs. Whether this translates to clinically meaningful bone outcomes (BMD, fracture risk) is less clear.

Effect size
~20–25% increase in fractional calcium absorption at 8–15 g/day in adolescents and postmenopausal women
Time to effect
Weeks to detect biomarker changes; bone-outcome trials are longer
Best fit
Adolescents during peak bone-mineral accrual or postmenopausal women already on adequate dietary calcium
Less likely
Adults with normal calcium status not at bone-health risk

Bottom line: Worth considering as a small adjunct in adolescents and postmenopausal women on adequate calcium intake.

Immune function and infection prevention

Supplement benefit
Limited Evidence

Prebiotic effects on immune function come mainly from infant-formula trials (reduced atopic dermatitis, reduced antibiotic prescriptions for infections) and a few adult trials showing improved vaccine antibody responses or reduced cold/flu incidence. Effect sizes in healthy adults are modest and inconsistent. The biology is plausible (microbiotaSCFAsTreg modulation), but the clinical evidence in adults is thinner than marketing implies.

Effect size
Modest effects on infection rates and vaccine responses in some trials; not consistent in healthy adults
Time to effect
Weeks to months in vaccine and infection trials
Best fit
Infants and children (most evidence is in pediatric formula trials); adults with recurrent respiratory infections wanting a low-cost adjunct
Less likely
Healthy adults expecting consistent infection reduction

Bottom line: Modest immune-support potential in some populations; not a primary use case.

IBS symptoms

Supplement benefit
Mixed Evidence

FOS is part of the FODMAP family (fermentable oligo-, di-, monosaccharides, and polyols) that frequently worsens IBS symptomsbloating, gas, abdominal pain. The Monash low-FODMAP approach for IBS specifically restricts fructans. A handful of small trials of FOS in IBS have shown either no benefit or worsening of symptoms in a meaningful subset of patients. Probiotics tend to have a better evidence base for IBS than prebiotics.

Effect size
Often worsens symptoms in IBS; rare improvements not robust
Time to effect
Often worse within days; not a useful trial
Best fit
None — most IBS patients react adversely to fructans
Less likely
Patients with diagnosed IBS, especially IBS-D or mixed

Bottom line: Don't use FOS for IBS. Follow a low-FODMAP approach instead.

Evidence is mixed

Some probiotic-prebiotic 'synbiotic' trials report symptom improvement in IBS, but the prebiotic component often blamed when symptoms worsen during dose titration.

How it works

FOS are indigestible by human enzymes but are selectively fermented by gut bacteria, particularly Bifidobacteria and Lactobacilli. This selective fermentation defines them as prebiotics. Fermentation produces short-chain fatty acids (acetate, propionate, butyrate) that support colonocyte energy, gut barrier function, and modulation of inflammation. Compared to longer-chain inulin, FOS ferments more rapidly in the proximal colon, producing more rapid effects on bacterial populations but also more gas. Research suggests FOS supplementation reliably increases beneficial Bifidobacteria populations, with effects observed within 1-2 weeks. FOS has demonstrated effects on bowel function, mineral absorption (particularly calcium and magnesium), and immune function. It may also influence satiety hormones and modestly affect glucose and lipid metabolism. By influencing the gut microbiome, FOS may have downstream effects on systemic inflammation and metabolic health.

How to take it

1. Typical dose
• Start low: 2–3 g/day for 1 week • Increase gradually to 5 g/day, then 10 g/day if tolerated • 5–10 g/day is the typical therapeutic range • Above 10 g/day, GI side effects (gas, bloating) increase significantly • Many adults already get 2–8 g/day from a regular diet (onion, garlic, wheat, banana)
2. Higher studied dose
Up to 20 g/day has been used in research but is generally poorly tolerated; calcium-absorption studies used 8–15 g/day.
3. Timing
With meals to minimise sudden colonic fermentation and reduce gas spikes. Spreading across 2–3 meals is gentler than a single large dose.
4. With food
With food.
5. Split dosing
Yes — split a 10 g daily dose into 5 g at two meals to reduce gas. Single-dose tolerance is much worse than divided.
6. How long to try
Indefinite if tolerated and you're enjoying the bifidogenic effect. For constipation, give 4 weeks before assessing; if no benefit, switch to psyllium or another fiber source.

What to track

Bloating, flatulence, abdominal discomfort during dose titration — common, dose-dependent, and the main reason people stop
Stool frequency and consistency (Bristol Stool Chart) if using for constipation
Other dietary FODMAP intake — FOS supplements add to the total fructan load
If you have IBS: any worsening of pain or bloating means stop

Bottom line: Start at 2–3 g/day with food, increase weekly to 5–10 g/day if tolerated. Stop or reduce dose if gas and bloating bother you — adherence is the main practical limit.

4 commercial forms

Compare the main delivery options and what they’re best suited for.

Short-chain FOS (oligofructose)

Most studied

Short-chain fructans (degree of polymerisation 39) — typically produced enzymatically from sucrose or extracted from chicory root and depolymerised. Rapidly fermented in the proximal colon. The form used in most trials and the basis for the 'FOS' label.

Rapidly fermented; strong bifidogenic effect; higher gas production per gram than long-chain inulin.

Inulin (long-chain)

Slower fermentation

Longer-chain fructans (DP up to 60), extracted from chicory root. Fermented more slowly and more distally in the colon than short-chain FOS, often producing less gas at equivalent doses. Frequently combined with FOS in 'inulin-FOS' blends.

Slower colonic fermentation; somewhat gentler GI tolerance at equivalent doses.

Inulin-FOS blends (Synergy 1, etc.)

Balanced

Mixtures of long-chain inulin and short-chain FOS designed for fermentation across the full colon length. Some products (Synergy 1) have specific evidence for calcium-absorption enhancement in adolescents and postmenopausal women.

Fermentation distributed proximal-to-distal; modestly better tolerated than pure FOS.

Galacto-oligosaccharides (GOS)

Alternative prebiotic

Different class of prebioticgalactose-based oligosaccharides derived from lactose. Often better tolerated than FOS in IBS patients and may be more selectively bifidogenic. Common in infant formula.

Comparable prebiotic effects; often better tolerated in adults with FODMAP sensitivity.

Safety

Know the common side effects, key cautions, and who should avoid it.

Common side effects

flatulenceabdominal bloatingabdominal crampingborborygmi (gut rumbling)loose stools at higher dosesincreased belching

Serious risks

Who should avoid it

Pregnancy & breastfeeding

FOS is generally regarded as safe in pregnancy and breastfeeding when taken at typical dietary or supplemental doses (≤10 g/day). It's added to many infant formulas. There are no specific dose recommendations for pregnancy supplementation; food-based intake from onion, garlic, banana, wheat is fine. If GI bloating during pregnancy is already an issue, supplemental FOS may worsen it.

Bottom line: FOS is safe in healthy adults but predictably triggers GI symptoms in people with IBS, SIBO, IBD, or FODMAP sensitivity. The dose-limiting step is almost always gas and bloating, not a medical risk.

Interactions

antibioticsMinor

Broad-spectrum antibiotics deplete Bifidobacteria and reduce the prebiotic effect of FOS during and shortly after treatment. Not a safety interaction; resume FOS after antibiotic course.

lactulose and other osmotic laxativesMinor

Additive fermentable-substrate load increases gas and bloating significantly. Avoid combining or use very low doses of each.

calcium and magnesium supplementsMinor

FOS modestly enhances divalent mineral absorption — beneficial for calcium status but theoretically could increase magnesium absorption to GI-symptom levels at very high mineral doses. Not clinically problematic at typical doses.

Food sources

Chicory root, raw

Amount
1 oz (12.0 g inulin/FOS)
%DV

Jerusalem artichoke (sunchoke), raw

Amount
½ cup (8.0 g inulin/FOS)
%DV

Garlic, raw

Amount
1 oz (5.0 g inulin/FOS)
%DV

Leek, raw

Amount
½ cup (3.5 g inulin/FOS)
%DV

Onion, raw

Amount
½ cup (2.5 g inulin/FOS)
%DV

Wheat bran

Amount
1 oz (1.5 g inulin/FOS)
%DV

Asparagus, raw

Amount
½ cup (1.5 g inulin/FOS)
%DV

Banana, ripe

Amount
1 medium (0.5 g inulin/FOS)
%DV

Whole wheat bread

Amount
1 slice (0.5 g inulin/FOS)
%DV

Rye, whole grain

Amount
1 oz (0.5 g inulin/FOS)
%DV

Barley, cooked

Amount
½ cup (0.3 g inulin/FOS)
%DV

Agave nectar

Amount
1 Tbsp (3.0 g inulin/FOS)
%DV

Choosing a product

What to look for on the label — and what to be skeptical of.

Look for

Source identified: short-chain FOS (oligofructose) typically derived from chicory root or produced enzymatically from sucrose
Degree of polymerisation (DP): short-chain FOS = DP 3–9; inulin = DP up to 60. FOS is the more rapidly-fermented end and tends to cause more gas
Grams of FOS per serving clearly stated — many 'fiber blend' products bury the actual FOS dose
Third-party tested (USP, NSF, ConsumerLab)
Single-ingredient powder if you want to titrate dose precisely
Sugar content: pure FOS is mildly sweet (~30% as sweet as sucrose); some products add additional sweeteners

Be skeptical of

'Weight loss' claims — prebiotic weight-loss trials in adults are weak and inconsistent
'Immune support' as a primary benefit in healthy adults — evidence is modest
'Detox' or 'cleanse' framing — meaningless biologically
Combination 'gut health' formulas that hide the FOS dose inside a proprietary blend
Mega-dose products (>15 g per serving) without explicit warnings about GI side effects
Products marketed specifically for IBS without warning about FODMAP class — fructans are a known IBS trigger
FOS-fortified bars, drinks, or snacks that don't list the FOS content — total daily fructan intake can easily exceed tolerable levels

Frequently asked questions

What is the difference between FOS and inulin?

Both are fructans (chains of fructose units). FOS has shorter chains (2-10 units); inulin has longer chains (10-60 units). FOS ferments faster and tends to cause more gas; inulin acts more slowly throughout the colon.

Why does FOS cause gas?

FOS is rapidly fermented by gut bacteria in the proximal colon, producing gases as a byproduct. Starting with small doses (1-2 grams) and gradually increasing helps the gut adapt over weeks.

Is FOS a prebiotic?

Yes, FOS is one of the best-studied prebiotics, reliably increasing Bifidobacteria and other beneficial bacteria in clinical trials.

Should I avoid FOS if I have IBS?

Generally yes, especially if you follow a low-FODMAP diet. FOS is a high-FODMAP fructan that commonly triggers IBS symptoms.

Can I take FOS with probiotics?

Yes, this combination is called a synbiotic and is common in commercial supplements. FOS provides food for the live bacteria, potentially supporting their growth and survival.

References by claim

Immune function and infection prevention

NCCIHProbiotics: What You Need To Know (2023) link

Lomax & Calder, 2009British Journal of Nutrition (2009) link

Bifidogenic effect (gut microbiota modulation)

Meyer & Stasse-Wolthuis, 2009European Journal of Clinical Nutrition (2009) link

Whelan, 2014Current Opinion in Clinical Nutrition and Metabolic Care (2014) link

Roberfroid, 2007Journal of Nutrition (2007) link

Constipation and stool frequency

Wilson & Whelan, 2017Journal of Gastroenterology and Hepatology (2017) link

Calcium absorption (adolescents and postmenopausal women)

Coxam, 2007Journal of Nutrition (2007) link

IBS symptoms

Monash University FODMAP DietMonash University — IBS Resource (2024) link

Other references

Bonnema et al., 2010Journal of the American Dietetic Association (2010) link

Track Fructo-Oligosaccharides (FOS) with Pilora

Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.

Coming to App Store
Evidence-based·Last reviewed May 31, 2026·Evidence current as of May 31, 2026·How we grade evidence

Disclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.